BlackRock’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.43M Sell
2,211,316
-145,496
-6% -$554K ﹤0.01% 3438
2025
Q1
$6.2M Buy
2,356,812
+73,639
+3% +$194K ﹤0.01% 3511
2024
Q4
$8.08M Buy
2,283,173
+429,424
+23% +$1.52M ﹤0.01% 3486
2024
Q3
$8.45M Buy
1,853,749
+85,080
+5% +$388K ﹤0.01% 3447
2024
Q2
$7.69M Sell
1,768,669
-32,941
-2% -$143K ﹤0.01% 3472
2024
Q1
$9.04M Sell
1,801,610
-61,829
-3% -$310K ﹤0.01% 3341
2023
Q4
$11.7M Buy
1,863,439
+134,319
+8% +$842K ﹤0.01% 3250
2023
Q3
$12.3M Sell
1,729,120
-308
-0% -$2.19K ﹤0.01% 3160
2023
Q2
$17.6M Buy
1,729,428
+1,617,539
+1,446% +$16.5M ﹤0.01% 3051
2023
Q1
$1.01M Buy
111,889
+47,727
+74% +$433K ﹤0.01% 4249
2022
Q4
$460K Sell
64,162
-640
-1% -$4.59K ﹤0.01% 4543
2022
Q3
$422K Buy
64,802
+14
+0% +$91 ﹤0.01% 4685
2022
Q2
$313K Buy
64,788
+6,905
+12% +$33.4K ﹤0.01% 4820
2022
Q1
$329K Sell
57,883
-1,602
-3% -$9.11K ﹤0.01% 4900
2021
Q4
$298K Buy
59,485
+1,380
+2% +$6.91K ﹤0.01% 4937
2021
Q3
$387K Sell
58,105
-4,092
-7% -$27.3K ﹤0.01% 4764
2021
Q2
$380K Sell
62,197
-266,972
-81% -$1.63M ﹤0.01% 4688
2021
Q1
$2.19M Buy
329,169
+6,866
+2% +$45.6K ﹤0.01% 4197
2020
Q4
$1.71M Buy
322,303
+62,827
+24% +$332K ﹤0.01% 4009
2020
Q3
$1.93M Buy
259,476
+1,116
+0.4% +$8.31K ﹤0.01% 3815
2020
Q2
$1.9M Buy
258,360
+238,148
+1,178% +$1.75M ﹤0.01% 3756
2020
Q1
$150K Buy
20,212
+316
+2% +$2.35K ﹤0.01% 4206
2019
Q4
$112K Buy
19,896
+2,306
+13% +$13K ﹤0.01% 4364
2019
Q3
$104K Sell
17,590
-990
-5% -$5.85K ﹤0.01% 4383
2019
Q2
$60K Sell
18,580
-326,307
-95% -$1.05M ﹤0.01% 4503
2019
Q1
$1.04M Sell
344,887
-13,356
-4% -$40.1K ﹤0.01% 3854
2018
Q4
$1.35M Buy
358,243
+7,094
+2% +$26.7K ﹤0.01% 3756
2018
Q3
$2.06M Buy
351,149
+3,063
+0.9% +$18K ﹤0.01% 3710
2018
Q2
$1.97M Buy
348,086
+59,617
+21% +$337K ﹤0.01% 3699
2018
Q1
$3.58M Buy
288,469
+287,105
+21,049% +$3.56M ﹤0.01% 3484
2017
Q4
$16K Buy
+1,364
New +$16K ﹤0.01% 4537